Studio Dragon Corp
KOSDAQ:253450
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
34 100
52 400
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Studio Dragon Corp
| Current Assets | 334.9B |
| Cash & Short-Term Investments | 148.2B |
| Receivables | 100.9B |
| Other Current Assets | 85.9B |
| Non-Current Assets | 567.1B |
| Long-Term Investments | 139.4B |
| PP&E | 18B |
| Intangibles | 277.9B |
| Other Non-Current Assets | 131.8B |
| Current Liabilities | 175.4B |
| Accounts Payable | 10B |
| Accrued Liabilities | 462m |
| Short-Term Debt | 1.5B |
| Other Current Liabilities | 163.5B |
| Non-Current Liabilities | 16.6B |
| Other Non-Current Liabilities | 16.6B |
Balance Sheet
Studio Dragon Corp
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
11 517
|
51 334
|
153 039
|
59 834
|
49 093
|
64 613
|
123 684
|
158 381
|
|
| Cash |
4
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
11 513
|
51 331
|
153 039
|
59 834
|
49 093
|
64 613
|
123 684
|
158 381
|
|
| Short-Term Investments |
2 550
|
141 286
|
6 700
|
56 723
|
51 936
|
5 342
|
4 888
|
2 999
|
|
| Total Receivables |
36 973
|
54 929
|
68 770
|
83 583
|
107 339
|
123 630
|
141 741
|
149 072
|
|
| Accounts Receivables |
36 973
|
54 929
|
68 770
|
83 583
|
106 669
|
123 630
|
141 741
|
149 072
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
670
|
0
|
0
|
0
|
|
| Inventory |
0
|
1 295
|
578
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
30 393
|
41 005
|
18 112
|
44 355
|
19 944
|
38 922
|
129 819
|
94 070
|
|
| Total Current Assets |
81 434
|
289 848
|
247 200
|
244 495
|
228 312
|
232 507
|
400 132
|
404 522
|
|
| PP&E Net |
1 227
|
1 062
|
986
|
7 957
|
14 708
|
15 069
|
16 219
|
19 323
|
|
| PP&E Gross |
1 227
|
1 062
|
986
|
7 957
|
14 708
|
15 069
|
16 219
|
19 323
|
|
| Accumulated Depreciation |
381
|
568
|
887
|
1 259
|
5 021
|
6 495
|
6 612
|
8 815
|
|
| Intangible Assets |
62 285
|
65 931
|
136 937
|
155 233
|
155 767
|
227 261
|
294 706
|
289 060
|
|
| Goodwill |
61 594
|
61 594
|
61 594
|
77 909
|
74 650
|
70 768
|
83 129
|
69 825
|
|
| Note Receivable |
0
|
0
|
13 113
|
20 387
|
25 430
|
13 672
|
31 680
|
12 071
|
|
| Long-Term Investments |
2 279
|
3 803
|
3 724
|
13 412
|
180 058
|
240 801
|
150 094
|
175 025
|
|
| Other Long-Term Assets |
33 215
|
37 215
|
48 820
|
62 163
|
78 374
|
83 952
|
114 706
|
122 398
|
|
| Other Assets |
61 594
|
61 594
|
61 594
|
77 909
|
74 650
|
70 768
|
83 129
|
69 825
|
|
| Total Assets |
242 035
N/A
|
459 454
+90%
|
512 375
+12%
|
581 557
+14%
|
757 300
+30%
|
884 028
+17%
|
1 090 666
+23%
|
1 092 226
+0%
|
|
| Liabilities | |||||||||
| Accounts Payable |
5 776
|
6 068
|
19 574
|
18 424
|
5 916
|
16 964
|
16 186
|
11 122
|
|
| Accrued Liabilities |
675
|
504
|
805
|
208
|
469
|
1 638
|
1 717
|
46
|
|
| Short-Term Debt |
8 120
|
0
|
0
|
0
|
0
|
0
|
170 000
|
170 000
|
|
| Current Portion of Long-Term Debt |
0
|
9 992
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
69 922
|
74 134
|
87 829
|
126 518
|
125 759
|
165 036
|
228 360
|
186 818
|
|
| Total Current Liabilities |
84 492
|
90 698
|
108 209
|
145 150
|
132 144
|
183 639
|
416 263
|
367 986
|
|
| Long-Term Debt |
19 934
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
952
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
548
|
312
|
2 880
|
8 157
|
15 808
|
16 525
|
13 673
|
16 470
|
|
| Total Liabilities |
105 926
N/A
|
91 010
-14%
|
111 089
+22%
|
153 307
+38%
|
147 952
-3%
|
200 164
+35%
|
429 935
+115%
|
384 456
-11%
|
|
| Equity | |||||||||
| Common Stock |
11 019
|
14 019
|
14 026
|
14 048
|
15 002
|
15 007
|
15 029
|
15 029
|
|
| Retained Earnings |
8 340
|
32 105
|
67 649
|
93 540
|
122 913
|
161 736
|
212 562
|
242 042
|
|
| Additional Paid In Capital |
114 744
|
319 582
|
320 102
|
321 743
|
470 027
|
470 387
|
473 363
|
473 363
|
|
| Other Equity |
2 008
|
2 738
|
491
|
1 081
|
1 405
|
36 735
|
40 223
|
22 664
|
|
| Total Equity |
136 110
N/A
|
368 443
+171%
|
401 286
+9%
|
428 250
+7%
|
609 347
+42%
|
683 864
+12%
|
660 731
-3%
|
707 770
+7%
|
|
| Total Liabilities & Equity |
242 035
N/A
|
459 454
+90%
|
512 375
+12%
|
581 557
+14%
|
757 300
+30%
|
884 028
+17%
|
1 090 666
+23%
|
1 092 226
+0%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
22
|
28
|
28
|
28
|
30
|
30
|
30
|
30
|
|
You don't have any saved screeners yet
